Search research articles
Contact Us
Filters
Showing results (161-170 of 176) with videos related to
Page
of 18
Sort By:
The Journal of Pediatrics
|
December 8, 2004
Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study
Thomas J A Lehman, Sharon J Schechter, Robert P Sundel, et al.
The New England Journal of Medicine
|
March 12, 1987
Hepatoerythropoietic porphyria: clinical, biochemical, and enzymatic studies in a three-generation family lineage
A C Toback, S Sassa, M B Poh-Fitzpatrick, et al.
Life Sciences
|
May 21, 1981
Increased gamma-aminobutyric acid (GABA), homocarnosine and beta-alanine in cerebrospinal fluid of patients treated with gamma-vinyl GABA (4-amino-hex-5-enoic acid)
J Grove, P J Schechter, G Tell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1987
Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea
A M Bonnet, G Tell, P J Schechter, et al.
Neuropediatrics
|
August 1, 1984
Gamma-aminobutyric acid-transaminase deficiency: a newly recognized inborn error of neurotransmitter metabolism
J Jaeken, P Casaer, P de Cock, et al.
Science (New York, N.Y.)
|
May 2, 1980
L-Ornithine decarboxylase:an essential role in early mammalian embryogenesis
J R Fozard, M L Part, N J Prakash, et al.
Journal of Animal Science
|
April 1, 1975
Plasma hormone levels in 6-methyl-17-acetoxyprogesterone and estradiol benzoate treated heifers
W Hansel, R J Schechter, P V Malven, et al.
The American Journal of Medicine
|
March 23, 1987
Difluoromethylornithine, an effective new treatment of Gambian trypanosomiasis. Results in five patients
H Taelman, P J Schechter, L Marcelis, et al.
Neurology
|
February 1, 1981
Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration
G Tell, P Böhlen, P J Schechter, et al.
Epilepsy Research
|
March 1, 1988
Effects of single doses of vigabatrin on CSF concentrations of GABA, homocarnosine, homovanillic acid and 5-hydroxyindoleacetic acid in patients with complex partial epilepsy
E B Menachem, L I Persson, P J Schechter, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 176) with videos related to
Sort By:
Page
of 18
The Journal of Pediatrics
|
December 8, 2004
Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study
Thomas J A Lehman, Sharon J Schechter, Robert P Sundel, et al.
The New England Journal of Medicine
|
March 12, 1987
Hepatoerythropoietic porphyria: clinical, biochemical, and enzymatic studies in a three-generation family lineage
A C Toback, S Sassa, M B Poh-Fitzpatrick, et al.
Life Sciences
|
May 21, 1981
Increased gamma-aminobutyric acid (GABA), homocarnosine and beta-alanine in cerebrospinal fluid of patients treated with gamma-vinyl GABA (4-amino-hex-5-enoic acid)
J Grove, P J Schechter, G Tell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1987
Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea
A M Bonnet, G Tell, P J Schechter, et al.
Neuropediatrics
|
August 1, 1984
Gamma-aminobutyric acid-transaminase deficiency: a newly recognized inborn error of neurotransmitter metabolism
J Jaeken, P Casaer, P de Cock, et al.
Science (New York, N.Y.)
|
May 2, 1980
L-Ornithine decarboxylase:an essential role in early mammalian embryogenesis
J R Fozard, M L Part, N J Prakash, et al.
Journal of Animal Science
|
April 1, 1975
Plasma hormone levels in 6-methyl-17-acetoxyprogesterone and estradiol benzoate treated heifers
W Hansel, R J Schechter, P V Malven, et al.
The American Journal of Medicine
|
March 23, 1987
Difluoromethylornithine, an effective new treatment of Gambian trypanosomiasis. Results in five patients
H Taelman, P J Schechter, L Marcelis, et al.
Neurology
|
February 1, 1981
Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration
G Tell, P Böhlen, P J Schechter, et al.
Epilepsy Research
|
March 1, 1988
Effects of single doses of vigabatrin on CSF concentrations of GABA, homocarnosine, homovanillic acid and 5-hydroxyindoleacetic acid in patients with complex partial epilepsy
E B Menachem, L I Persson, P J Schechter, et al.
Page
of 18